Clinical Trial Detail

NCT ID NCT03307785
Title Study of Niraparib or Carboplatin-Paclitaxel in Combination With TSR-042
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

Advanced Solid Tumor

Therapies

Carboplatin + Dostarlimab + Paclitaxel

Dostarlimab + Niraparib

Age Groups: adult senior

No variant requirements are available.